Get the app
US › Healthcare

Tonix Pharmaceuticals Holding Corp (TNXP)

US · Healthcare · Biotechnology

$11.42-2.89%
Last close · 2026-09-17

Latest quarter · ended 2026-06-30

Revenue
$13.5M
Revenue YoY
+577.9%
Net profit
$-40.6M
EPS
$-2.44
EPS estimate
$-2.71
Net margin
-299.4%

EPS came in at -2.44 against a street estimate of -2.71 — a beat of 10.0%.

Key statistics

Market cap
$210.6M
Forward P/E
0.0
P/B
0.99
Book value
$13.24
EPS (TTM)
$-12.53
52-week high
$29.19
52-week low
$9.40
50-day MA
$12.13
200-day MA
$14.07
Beta
1.75

Analyst view

Analysts rate Tonix Pharmaceuticals Holding Corp a strong buy (2 buy, 0 hold, 0 sell out of 2) with an average price target of $42.40.

Shareholding

Insiders
0.16%
Institutions
55.98%

Largest institutional holders

FundStake
BlackRock Inc5.64%
Millennium Management LLC5.64%
Jones Hill Capital LP3.65%
Vanguard Capital Management, LLC3.02%
Citadel Advisors Llc2.73%
Geode Capital Management, LLC1.83%
Balyasny Asset Management LLC1.83%
UBS Group AG1.35%

See the full picture

Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for Tonix Pharmaceuticals Holding Corp — free to start.

Google PlayApp Store

Other Healthcare companies

Eli Lilly and CompanyJohnson & JohnsonAbbVie IncMerck & Company IncUnitedHealth Group IncorporatedNovartis AG ADRAstraZeneca PLCThermo Fisher Scientific IncAmgen IncNovo Nordisk A/SGilead Sciences IncAbbott Laboratories

Data updated 2026-09-18.